The existing extensive laboratory data on trichloroethylene (TCE) and its two metabolites, dichloroacetic (DCA) and trichloroacetic (TCA), are used to explore the relationship among these three compounds. Under the hypothesis that these compounds induce liver tumors in mice through promotion of preexisting initiated cells, it is demonstrated that DCA alone could be responsible for all the response of carcinomas in liver of B6CF, mice. The focus of this paper is on how a plausible biological assumption could impact on low-dose risk estimates, rather than on the risk estimate per se. The findings suggest that low-dose risk estimates to humans would be overestimated unless the different background rates between mice and humans are properly accounted for. (1, (3) (4) (5) , with water concentrations ranging from 0.05 to 5 mg/L (considered as one data set); c) two TCE bioassays (6,7) with gavage doses ranging from 1,000 to 2,400 mg/kg/day; d) one TCE inhalation bioassay (8) with air concentrations ranging from 100 to 600 ppm; and e) an initiation-promotion (IP) study (3) Because TCE may affect the growth of neoplastic lesions, the model should include a parameter reflecting such an effect. Furthermore, the model should allow for piecewise constant parameters because some parameters (e.g., cell mitotic rate) are known to be age dependent (10), and the data available have different exposure levels over time. For instance, in the low-dose group of the National Cancer Institute (NCI)TCE bioassay (6), animals were exposed to 1,000 mg/kg/day of TCE by gavage from age 5 weeks to 17 weeks, 1,200 mg/kg/day from age 17 weeks to 83 weeks, and followed up to age 95 weeks; in the high-dose group, exposure was 2,000 mg/kg/day from age 5 weeks to 17 weeks, 2,400 mg/kg/day from age 17 weeks to 83 weeks, and followed up to age 95 weeks. Under this experimental condition, the dose-affected parameters would have different values over different subintervals, with cutoff points at ages 5, 17, and 83 weeks. Exact exposure pattern over ages is used in all modelings considered in this report.
Although there is a large data gap before a true biologically based dose-response (BBDR) model can be constructed for mouse liver tumors, it is desirable to use the existing extensive bioassay data on trichloroethylene (TCE) and its two metabolites, dichloroacetic (DCA) and trichloroacetic (TCA), to explore the relationship among these three compounds and to evaluate its potential impacts on low-dose extrapolation. Data available include a) midto long-term DCA bioassays from different investigators (1) (2) (3) (4) (5) , with water concentrations ranging from 0.05 to 5 mg/L (considered as one data set); b) mid-to long-term TCA bioassays from different investigators (1, (3) (4) (5) , with water concentrations ranging from 0.05 to 5 mg/L (considered as one data set); c) two TCE bioassays (6,7) with gavage doses ranging from 1,000 to 2,400 mg/kg/day; d) one TCE inhalation bioassay (8) with air concentrations ranging from 100 to 600 ppm; and e) an initiation-promotion (IP) study (3) with ethylnitrosourea (ENU) as initiator and TCE, DCA, and TCA as promoters (considered as three data sets). Data from all these studies include incidence rates of carcinomas and average number of carcinomas per animal. There is also supplemental laboratory information such as labeling index on normal hepatocytes, and c-Jun-positive cells by DCA, as reported in the mode of action paper by Bull (9) . Given such an extensive data set, it is desirable to use these data to investigate the feasibility of a biological hypothesis and to investigate their implications on low-dose extrapolation. In addition to mouse liver tumors, TCE also induces other tumors (e.g., lung and kidney) in rats.
However, the existing database is not sufficient to develop BBDR models for such tumors.
Specific Objectives
On the basis of bioassay data on TCE and its metabolites (DCA and TCA), it is possible to perform statistical analyses to investigate the feasibility of a biological hypothesis proposed by researchers: TCE induces liver tumors mainly via its metabolites, DCA and/or TCA. Both metabolites (DCA and TCA) act through the clonal expansion of preexisting initiated cells.
Under this hypothesis, animals with a higher background tumor incidence are expected to be more susceptible to tumor induction from TCE exposure, assuming that higher background tumor incidence is due to higher frequence of spontaneously induced initiated cells. Therefore, confirmation of this hypothesis would have profound implications on low-dose extrapolation. It should be emphasized, however, that the conclusions reached from our statistical investigations can at most serve as tentative guidance for future research to improve low-dose extrapolation; mathematical analyses alone cannot replace the need for actual laboratory investigations.
Our analyses focus on carcinomas in male mice because these data are more complete in male than in female mice. We recognize that other plausible hypotheses about liver tumors in mice can be postulated. For instance, hypotheses about interrelationships among preneoplastic and neoplastic lesions (foci, hyperplastic nodules, adenomas, and carcinomas) may be postulated. However, it requires more biological insight than presently available to support a particular hypothesis. It should be emphasized that the purpose of this paper is not to provide unit risk estimates; it is to demonstrate how a biological assumption could impact risk estimates at low doses even if the exact shape of the dose-response function is not known.
Preliminary Considerations
In this article, we focus on analysis of tumor incidence data, using other information (i.e., labeling index [LI] of c-Jun-positive cells, and averaged numbers of tumors/animal) to evaluate the reasonableness of statistically estimated parameters related to mitotic rate of initiated cells in the model. Since the LI for c-Jun-positive cells is available only for an age of about 45 weeks, it can only be used to check the reasonableness of statistically estimated parameters related to cell division rate of initiated cells around comparable ages. Our model allows the rate to vary over the animal's lifespan in a piecewise constant manner.
As mentioned earlier, if all lesions (e.g., foci, hyperplastic nodules, adenomas, and carcinomas) are considered together, a model of multiple-pathway carcinogenesis may be more appropriate. This approach is not adopted here because it would involve more assumptions requiring more data, and thus make any meaningful inference impossible. However, these types of data are very useful for constructing a BBDR model.
Because TCE may affect the growth of neoplastic lesions, the model should include a parameter reflecting such an effect. Furthermore, the model should allow for piecewise constant parameters because some parameters (e.g., cell mitotic rate) are known to be age dependent (10) , and the data available have different exposure levels over time. For instance, in the low-dose group of the National Cancer Institute (NCI)TCE bioassay (6) , animals were exposed to 1,000 mg/kg/day of TCE by gavage from age 5 weeks to 17 weeks, 1, 200 mg/kg/day from age 17 weeks to 83 weeks, and followed up to age 95 weeks; in the high-dose group, exposure was 2,000 mg/kg/day from age 5 weeks to 17 weeks, 2,400 mg/kg/day from age 17 weeks to 83 weeks, and followed up In this report, we adopt the biological framework (but not the deterministic formulation) suggested by Cohen and Ellwein (10) , as well as the stochastic formulation by Chen and Farland (11) and its extended version (12) . Three special features of this model are a) the mitotic rate is explicitly incorporated in the model, b) unlike most other two-stage models, a single malignant cell may not necessarily become a tumor, and c) the model allows for piecewise constant parameters. As in all two-stage models, the parameters cannot be uniquely estimated using a statistical optimization procedure (13) .
An approach preferred by statisticians is to reparametertize parameters. Although this approach is statistically appropriate, it defeats the main objective of our investigation; namely, to evaluate the implication of the resultant model on low-dose extrapolation. It should be noted that it is important to keep each parameter as originally defined because the essential purpose of BBDR modeling is to study the behavior of dose response at low doses, and because the shape of the dose-response function at low doses is a function of the shape of each individual exposurerelated parameter in a model (14) . An There are three TCE bioassays available: gavage studies by NCI (6) and National Toxicology Program (NTP) (7), and an inhalation study by Bell et al. (8) . For the NCI study (6) , animals in the low-dose group were exposed to 1,000 mg/kg/day of TCE by gavage from age S weeks to 17 weeks, 1,200 mg/kg/day from age 17 weeks to 83 weeks, and followed up to age 95 weeks; animals in the high-dose group were exposed to 2,000 mg/kg/day from age 5 weeks to 17 weeks, 2,400 mg/kg/day from age 17 weeks to 83 weeks, and followed up to age 95 weeks. For the NTP study (7), animals were exposed to 1,000 mg/kg/day of TCE by gavage from age 5 weeks to 1 10 weeks. Animals (male mice) in the study of Bell et al. (8) were exposed to TCE by inhalation for 6 hr/day, 5 days/week, 104 weeks. For both NCI and NTP studies in Table  3 , observed values are Kaplan-Meier estimated lifetime tumor incidence after adjusting for intercurrent mortality. However, only crude incidences are given for Bell's inhalation study because the time-to-event data are not available. Since crude incidence tends to underestimate true tumor rate because of intercurrent mortality, it is expected that predicted incidence is higher than the crude incidence as given in Table 3 . Because the background incidences differ significantly among studies, comparison of predicted versus observed responses are made in terms of excess incidence = P(t,d) -P(t,O), where t is the age at end of study. As discussed later, the excess risk is not the best way to remove Table 5 , the model-based estimates of cell division rate around age 45 weeks appear to be comparable to the laboratory-based values, which are converted from LI to cell division rates by using a formula proposed by Moolgavkar and Luebeck (19) . Note that these formula-converted rates are themselves subject to uncertainty because the formula can only be considered an approximation of reality.
Data on Number of Carcinomas per Animal
The number of tumors per animal is very useful data for constructing a biologically based dose-response model. However, these data cannot be used in modeling because the individual animal data are not available; for each dosed group, only average number of tumors per animal is available. To use these data, we summarized in Table 6 all available bioassays that consist of groups of animals exposed to both DCA and TCA at the same dose level and duration, with a sample size of 20 Table 7 . The analysis performed in this section is more to provide insight into the problem than to solve the problem itself.
If AUC in blood derived from Clewell's PBPK model is used as a dosimeter, it is possible to find a set of parameters from DCA and TCA that are capable of predicting tumor response in TCE oral bioassays (even though the predicted value for the high-dose group in the NCI study falls slightly below the 95% CI), but overpredict the response in the inhalation study (Table 7) . One may argue, however, that the inhalation study's failure to predict could be explained by the fact that the AUC of DCA and TCA in blood after inhalation exposure to TCE differs (overestimated) from the AUC after gavage administration, which is the basis of data used to construct dose-response models for DCA and TCA (used to predict tumor response in TCE bioassays). If this argument is accepted, one could conclude that both TCA and DCA are responsible for TCEinduced tumors, even though the overall prediction result is not as good as the results when Fisher's model was used. As can be seen from Table 7 , TCA appears to account for more than 70% of TCE-induced carcinomas.
Implications of Results for Risk Assessment
The conclusion that DCA (and possibly TCA also) is responsible for TCE-induced tumors by acting on spontaneously induced initiated cells has a profound implication on extrapolating risk from mice to humans. As demonstrated in Table 8 , the excess risk at a given dose is more than 90-fold higher for a group with higher tumor background rate (0.23 for male mice) than for a group with lower background rate (0.002 for humans).
To extrapolate risk to humans from animal-based models, it is assumed that lifetime risk to humans can be calculated from the lifetime risk of animals by adjusting (reducing) the initiation parameter in the animal model so that the background lifetime risk is reduced from 0.23 for male, mice to 0.002 for humans. On the basis of the Fisher model, AUC-TCA in liver is estimated to be 3.8 x 10-3 when humans are exposed to 1 g/L of TCE in water. The model does not provide an estimate for AUC-DCA. The lack of DCA in the human model is because there is no clear evidence of its formation in humans. In the absence of better data, one may assume that the ratio of AUC-DCA/(AUC-DCA + AUC-TCA), which is about 1% in mice, is identical with that of humans. Under this assumption, we see from Table 8 that the unit risk is reduced from 2.486 x 10-6 to 2.447 x 10-8 if the background tumor rate is reduced from 0.23 to 0.002, a 100-fold reduction of excess risk. C.W. CHEN (9) . The importance of knowing dose-response relationships for cell dynamic parameters in a dose-response model has been discussed by Crump (14) . Crump (14) has shown that, at low doses, the shape of tumor dose-response function is completely dependent on the dose-response function of dose-dependent model parameters. A potentially useful knowledge may be gained if the relationship between different preneoplastic and neoplastic lesions is understood. These end points, which include various types of foci, hyperplastic nodules, adenomas, and carcinomas, suggest that different mechanisms may induce liver tumors; some may be compound dependent and some may be spontaneously induced. It is difficult to conceive that these lesions are linearly related, meaning that one is a prerequisite for the others in linear sequence. This problem suggests the need to develop a more flexible modeling procedure than the two-stage models now used.
More Flexible Modeling Ptocedures
To understand the need for new modeling approaches, we have to discuss the shortcomings of existing approaches. Most (12) and is an extension of a stochastic model developed by Chen and Farland (11) . This model has a biological motivation similar to the two-stage model proposed by Greenfield et al. (21) , which has been used by Cohen and Ellwein (22) to analyze bladder tumors. However, the two models differ from each other with respect to their mathematical formulations; the one adopted in this report is a stochastic model, whereas the other is a deterministic model that does not allow for parameter estimation because it does not have complete mathematical expression.
Although its most general form will not be used here because of the lack of data, it is worthwhile to note that the stochastic model of Chen and Farland (11) 
